Newsletters
EARL
Overview
Designed to be the new reference platform for the broader, multidisciplinary community involved in nuclear medicine, EANM Innovation will highlight significant contributions from professionals across the field, fostering knowledge exchange and collaboration.
EANM Innovation focuses on clinical, preclinical, and technological studies developing and exploring the use of radiopharmaceuticals and other imaging probes in diagnosis and therapy
The journal is open access and published with a continuous working model. For more information, please visit the journal website.
To find out more about the article types, manuscript requirements, and editorial policies, feel free to browse our submission guidelines.
Please submit your manuscript through our online submission portal.
For regular updates follow its 
LinkedIn page.
Submission process
Questions & contact
Do you have any questions regarding:
- Manuscript preparation
- Editorial workflow
- Peer-review process
- Pre-submission inquiry
Feel free to contact Esther Pilla (EANM Editorial Manager) at eanm.journal@eanm.org.
Editorial Board
Editor-in-Chief: Riemer Slart
Associate Editors:
- Ali Afshar-Oromieh
- Ronald Boellaard
- Henry Hee-Seung Bom
- Arturo Chiti
- Alberto Cuocolo
- Dawei Jiang
- Silvia Morbelli
- Ruiqing Ni
- Axel Rominger
- Mike Sathekge
- Fang Xie
Frequently Asked Questions
Choose EANM Innovation if your paper is primarily about nuclear medicine application, implementation, multidisciplinary practice, technology, optimization, or concise “hot topic” contributions (e.g. short communications and hotspot formats).
Original Articles, Procedure Guidelines, Systematic Reviews, Case Reports, Hotspot, and Letters to the Editor.
Journals must meet certain criteria, including a minimum number of published articles, before being included in major databases. By contributing your work, you can help EANM Innovation achieve this milestone more quickly. Additionally, some databases may retroactively index previous issues once the journal is accepted.
Your manuscript will still gain considerable visibility through Elsevier’s ScienceDirect platform, which reaches a broad global audience. Additionally, each issue is actively promoted through our newsletters and social media channels, amplifying the reach and impact of your work.
You will benefit from a streamlined peer-review and publication process, and early contributions play a crucial role in building the journal’s reputation and helping it earn an impact factor in the future. Since both journals are fully open access, your research will be instantly accessible to readers worldwide.
You can submit your manuscript free of Article Processing Charges (APC) until December 31, 2026. After this date, an APC will be charged for accepted articles; however, Elsevier provides several agreements that may minimize or even eliminate these costs.
Contact us by email at office@eanm.org and we will guide you through the registration process in our editorial platform.
You can reach us by email at editorial.office@eanm.org. We are happy to support you every step of the way! Check our submission guidelines here.